THBS1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, plasma TSP1 expression is increased in NAFLD human patients and reduced after fat-lowering lifestyle intervention, which is consistent with the ability of TSP1 to inhibit the uptake of free fatty acids via CD36 in endothelial cells [23,24].